Didanosine, Lamivudine, and Efavirenz versus Zidovudine, Lamivudine, and Efavirenz for the Initial Treatment of HIV Type 1 Infection: Final Analysis (48 Weeks) of a Prospective, Randomized, Noninferiority Clinical Trial, GESIDA 3903 - Concepedia

Concepedia

Publication | Open Access

Didanosine, Lamivudine, and Efavirenz versus Zidovudine, Lamivudine, and Efavirenz for the Initial Treatment of HIV Type 1 Infection: Final Analysis (48 Weeks) of a Prospective, Randomized, Noninferiority Clinical Trial, GESIDA 3903

DOI Full Paper Access

35

Citations

22

References

2008

Year

Juan Berenguer, Juan González, Esteban Ribera, Peré Domingo, Jesús Santos, Pilar Miralles, Ma Angels Ribas, Víctor Asensi, J. Gimeno, José A. Pérez‐Molina,

Clinical Infectious Diseases

Abstract

NCT00256828.

References

	Year	Citations

Page 1